Speaker illustration

Doctor John Adams

Arena Pharmaceuticals, San Diego (United States of America)

Relative bioavailability and pharmacokinetic (PK) performance of a ralinepag extended-release (XR) tablet oral formulation and the effect of food and gender in healthy human subjects

Event: ESC Congress 2018

Topic: Pulmonary Hypertension

Session: Pulmonary hypertension: progress in management, impact on outcomes

Thumbnail

Comparative receptor pharmacology, pre-clinical efficacy and pharmacokinetics of a novel, next-generation prostacyclin receptor agonist, ralinepag (APD811), in humans and rats

Event: ESC CONGRESS 2017

Topic: Chronic pulmonary hypertension

Session: Progress in the management of pulmonary hypertension

Thumbnail

ESC 365 is supported by

logo Novo Nordisk